Literature DB >> 196859

Impaired responsiveness to the effect of glucagon on plasma adenosine 3':5'-cyclic monophosphate in normal man.

G N Hendy, S Tomlinson, J L O'Riordan.   

Abstract

Small doses (10-150 microgram; 3-45 nmol) of glucagon caused a dose-dependent increase in plasma adenosine 3':5'-cyclic monophosphate (cyclic AMP) concentration when injected into man. Infusion of glucagon (75 ng min-1 kg-1) for 2 h into normal subjects resulted in an initial increase in plasma cyclic AMP concentration, then a decline despite continuation of the hormone infusion and maintenance of high concentrations of circulating immunoreactive glucagon. When an injection of glucagon was given at the termination of such an infusion, the subsequent increase in plasma cyclic AMP concentration was markedly reduced when compared to that observed after a control injection which had not been preceded by a glucagon infusion. When the glucagon was injected at the end of an infusion of 1000 MRC units of bovine parathyroid hormone (BPTH) over 2 h, the plasma cyclic AMP response was normal. Conversely, after infusion of glucagon the response to injected BPTH was normal. This impairment of response was therefore specific to the hormone that had been administered and was not due to altered metabolism of circulating cyclic AMP. This phenomenon may be important in the regulation of the hormonal response by the target tissue.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 196859     DOI: 10.1111/j.1365-2362.1977.tb01591.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  6 in total

1.  The extracellular cAMP-adenosine pathway regulates expression of renal D1 dopamine receptors in diabetic rats.

Authors:  Eldo V Kuzhikandathil; Leslie Clark; Ying Li
Journal:  J Biol Chem       Date:  2011-07-29       Impact factor: 5.157

2.  Cyclic AMP metabolism and adenylate cyclase concentration in patients with advanced hepatic cirrhosis.

Authors:  A Francavilla; A F Jones; T E Starzl
Journal:  Gastroenterology       Date:  1978-12       Impact factor: 22.682

3.  Investigation of the usefulness of the plasma adenosine 3' 5' - cyclic monophosphate response to glucagon in thyroid disease.

Authors:  S Mac Neil; G N Hendy; H Amirrasooli; P R Daggett; S Tomlinson
Journal:  J Endocrinol Invest       Date:  1980 Oct-Dec       Impact factor: 4.256

4.  Cyclic AMP is a hepatorenal link influencing natriuresis and contributing to glucagon-induced hyperfiltration in rats.

Authors:  M Ahloulay; M Déchaux; C Hassler; N Bouby; L Bankir
Journal:  J Clin Invest       Date:  1996-11-15       Impact factor: 14.808

5.  Anomalous plasma cyclic AMP responses to glucagon in patients with liver disease.

Authors:  H Maekubo; T Matsushima; F Okada; M Honma; M Ui
Journal:  Dig Dis Sci       Date:  1980-09       Impact factor: 3.199

6.  High-Dose Glucagon Has Hemodynamic Effects Regardless of Cardiac Beta-Adrenoceptor Blockade: A Randomized Clinical Trial.

Authors:  Kasper M Petersen; Søren Bøgevig; Troels Riis; Niklas W Andersson; Kim P Dalhoff; Jens J Holst; Filip K Knop; Jens Faber; Tonny S Petersen; Mikkel B Christensen
Journal:  J Am Heart Assoc       Date:  2020-10-26       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.